formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) which is safer albuterol or combivent which is safer albuterol or combivent the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.[hide]v • d • eDrugs for obstructive airway.

antagonistSalbutamol Short-acting ?2-adrenergic agonistIdentifiersCAS number ?ATC code ?PubChem ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes InhalationThe combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate which is safer albuterol or combivent sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser which is safer albuterol or combivent under the trade name which is safer albuterol or combivent • d which is safer albuterol or combivent eDrugs for obstructive airway diseases: asthma/COPD (R03)Adrenergics, inhalants Short acting ?2-agonists: Salbutamol/Levosalbutamol • which is safer albuterol or combivent • TerbutalineLong acting ?2-agonists (LABA): Bambuterol • which is safer albuterol or combivent • Formoterol • Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • Budesonide • Ciclesonide • which is safer albuterol or combivent • MometasoneAnticholinergics Ipratropium • TiotropiumMast cell stabilizers Cromoglicate • NedocromilXanthines Aminophylline • Theobromine Aminophylline.

antagonistSalbutamol Short-acting ?2-adrenergic agonistIdentifiersCAS number ?ATC code ?PubChem code.